Thoracic endovascular repair versus open surgical repair — which is the more cost-effective intervention for descending thoracic aortic pathologies?☆

Abstract

TEVAR is associated with reduced morbidity and mortality in the short term. However, no cost benefit was seen with TEVAR even in the short term. In the long term, due to increased risk of re-interventions TEVAR may actually prove to be a more expensive therapeutic option.